<DOC>
	<DOCNO>NCT02772185</DOCNO>
	<brief_summary>This study double blind , sham-controlled clinical trial aim compare long-term effect stimulation Alzheimer 's Disease ( AD ) . Sixty early AD patient take part phase II/III clinical study 1-year period . The study involve transcranial direct current stimulation ( tDCS ) , cognitive training ( CT ) , detailed neuropsychological neurological testing . These assessment occur baseline , two month ( end point ) . Those achieve clinical improvement neurostimulation cognitive therapy invite receive treatment 12 month part follow-up study .</brief_summary>
	<brief_title>Neurostimulation Cognitive Intervention Alzheimer 's Disease</brief_title>
	<detailed_description>The patient randomize 1 4 group : active tDCS plus real CT , active tDCS plus placebo CT , sham tDCS plus real CT , sham tDCS plus placebo CT. Each group receive treatment 30 minute day , 3 day week 8 week .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Male female age 6090 year Patients diagnose Alzheimer 's Disease , accord DSMIV ( Diagnostic Statistical Manual Mental Disorders ) NINCDSADRDA ( National Institute Communicative Disorders Stroke Alzheimer 's Disease Related Disorders Association ) criteria Score 18 26 Mini Mental State Examination Have CDR ( Clinical Dementia Rating ) 1.0 If medicate AD , use cholinesterase inhibitor , least 3 month stable dose least 60 day prior screen . Preexisting structural brain abnormality , Other neurologic psychiatric diagnosis Transcranial direct current stimulation criterion : patient implant metallic electronic device ; pacemaker ; seizure ; pregnancy ; condition might limit interfere sensorimotor system</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>